DE69636052D1 - Mpl-liganden analoga - Google Patents

Mpl-liganden analoga

Info

Publication number
DE69636052D1
DE69636052D1 DE69636052T DE69636052T DE69636052D1 DE 69636052 D1 DE69636052 D1 DE 69636052D1 DE 69636052 T DE69636052 T DE 69636052T DE 69636052 T DE69636052 T DE 69636052T DE 69636052 D1 DE69636052 D1 DE 69636052D1
Authority
DE
Germany
Prior art keywords
mpl
mpl ligand
analogs
ligand analogue
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636052T
Other languages
English (en)
Other versions
DE69636052T2 (de
Inventor
Steven G Elliott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,779 external-priority patent/US5696250A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE69636052D1 publication Critical patent/DE69636052D1/de
Application granted granted Critical
Publication of DE69636052T2 publication Critical patent/DE69636052T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69636052T 1995-02-15 1996-02-13 Mpl-liganden analoga Expired - Fee Related DE69636052T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/388,779 US5696250A (en) 1995-02-15 1995-02-15 DNA encoding megakaryocyte growth and development factor analogs
US388779 1995-02-15
US08/591,070 US5756083A (en) 1995-02-15 1996-02-09 Mpl ligand analogs
US591070 1996-02-09
PCT/US1996/002492 WO1996025498A2 (en) 1995-02-15 1996-02-13 Mpl ligand analogs

Publications (2)

Publication Number Publication Date
DE69636052D1 true DE69636052D1 (de) 2006-05-24
DE69636052T2 DE69636052T2 (de) 2007-04-12

Family

ID=27012437

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636052T Expired - Fee Related DE69636052T2 (de) 1995-02-15 1996-02-13 Mpl-liganden analoga

Country Status (11)

Country Link
EP (1) EP0811064B1 (de)
JP (1) JP3836877B2 (de)
CN (1) CN1161468C (de)
AT (1) ATE323724T1 (de)
AU (1) AU691410B2 (de)
CA (1) CA2209298C (de)
DE (1) DE69636052T2 (de)
HK (2) HK1005807A1 (de)
MX (1) MX9705943A (de)
NZ (1) NZ303588A (de)
WO (1) WO1996025498A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357513B1 (en) 1994-01-03 2013-01-22 Genentech, Inc. Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
US8241900B1 (en) 1994-01-03 2012-08-14 Genentech, Inc. mpl ligand
US8192955B1 (en) 1994-01-03 2012-06-05 Genentech, Inc. Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof
US5989538A (en) * 1995-02-15 1999-11-23 Amgen Inc. Mpl ligand analogs
MX340738B (es) * 1996-09-13 2016-07-22 Shire Human Genetic Therapies Terapia para deficiencia de a-galactosidasa a.
KR100408229B1 (ko) * 1996-10-04 2003-12-01 암겐 인코포레이티드 Ｍｐｌ 리간드를 함유하는 제약학적 조성물
KR20000006549A (ko) * 1998-06-30 2000-01-25 윤재승 생체내혈소판증식효능이향상된신규한트롬보포이에틴유도체
US20030228666A1 (en) 1998-06-30 2003-12-11 Daewoong Pharmaceutical Co., Ltd. Novel human thrombopoietin mutein
US6376242B1 (en) 1999-09-21 2002-04-23 Emory University Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents
AU2003271194A1 (en) * 2003-10-09 2005-04-21 Daewoong Co., Ltd. Process for purifying human thrombopoietin with high content of sialic acid
US20110294733A1 (en) 2009-01-20 2011-12-01 Hanall Biopharma Co., Ltd. Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
US20150038362A1 (en) * 2012-02-27 2015-02-05 Biogen Idec Ma Inc. High-Throughput Method For Sialic Acid Quantitation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19500030A1 (de) * 1994-01-03 1995-07-06 Genentech Inc Thrombopoietin
GB2285446B (en) * 1994-01-03 1999-07-28 Genentech Inc Thrombopoietin
SG79882A1 (en) * 1994-02-14 2001-04-17 Kirin Brewery Protein having tpo activity
CZ288926B6 (cs) * 1994-03-31 2001-09-12 Amgen Inc. MGDF derivát, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
AU4163196A (en) * 1994-11-30 1996-06-19 Zymogenetics Inc. Low molecular weight thrombopoietin
JPH11500308A (ja) * 1995-02-03 1999-01-12 ジー．ディー．サール アンド カンパニー 新規ｃ−ＭＰＬリガンド

Also Published As

Publication number Publication date
CA2209298A1 (en) 1996-08-22
EP0811064B1 (de) 2006-04-19
DE69636052T2 (de) 2007-04-12
CN1182453A (zh) 1998-05-20
ATE323724T1 (de) 2006-05-15
HK1009151A1 (en) 1999-09-10
AU4994696A (en) 1996-09-04
EP0811064A2 (de) 1997-12-10
JP3836877B2 (ja) 2006-10-25
NZ303588A (en) 1999-02-25
CN1161468C (zh) 2004-08-11
JPH11500904A (ja) 1999-01-26
HK1005807A1 (en) 1999-01-29
AU691410B2 (en) 1998-05-14
CA2209298C (en) 2001-12-18
MX9705943A (es) 1997-10-31
WO1996025498A2 (en) 1996-08-22
WO1996025498A3 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
RU95115239A (ru) Аналог эритропоэтина
EP1440980A3 (de) Peptidanaloge des menschlichen, basischen Myelinproteins
PT662827E (pt) Metodos de diagnostico e composicoes farmaceuticas a base de proteinas notch e acidos nucleicos
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
ATE114169T1 (de) Morphogenetisches knochenprotein.
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
AU3498189A (en) Fibronectin binding protein
ATE323724T1 (de) Mpl-liganden analoga
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
HU9200548D0 (en) Improved activity process of recombined proteins
ATE363488T1 (de) Zusammensetzungen von stammzellfaktor (scf)- analogen und auf diese bezogene verfahren
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee